A store opening that isn’t really about a store
When Chemist Warehouse anchors a purpose-built 800sqm retail building on the corner of Hawthorne Dr and Glenda Dr in Frankton Flats, it will look like another big-box opening. It isn’t. As the Otago Daily Times reports, the site sits directly across from Pak’n Save and alongside the Five Mile and Queenstown Central precincts, what developer Michael Spektor of National Retail Group calls “the best corner in Frankton, in Queenstown, from a retail perspective.”
Spektor, whose company is the chain’s real estate partner, says finding it took time: “We tried to get into a number of developments that, frankly, the developers just couldn’t stack up.” The building, going up courtesy of Wānaka’s Calder Group, targets a Christmas 2026 opening. A second 503sqm tenancy in the same building already has roughly seven prospective tenants circling, a sign of what Spektor describes as serious pent-up demand because “Queenstown hasn’t had any new buildings going up near the airport for a very long time.”
This is Chemist Warehouse’s second Queenstown location inside roughly 12 months, following a prominent corner site in the CBD. That cadence is the story.
Becoming the market, not competing in it
The chain isn’t a strong player in New Zealand pharmacy. It is the market. BusinessDesk reported in April 2026 that Chemist Warehouse holds 66% of the retail pharmacy market and plans to double its footprint from 70 stores to 140 within five to ten years. Network sales from its New Zealand stores topped A$1 billion (around NZ$1.2 billion) for the first time in the year to June 2025.
The operator, Pharmacy Investments Group, has been working the policy angle too, lobbying Regulations Minister David Seymour for changes that would let it run large-scale centralised dispensing robotics, add pharmacists to the Immigration NZ Green List, and expand over-the-counter medicine access. The group also claims its discount scheme has saved consumers $63 million. Owner Sigma Healthcare completed a reverse acquisition in early 2025 and recently made an unsuccessful tilt at UK chain Boots, per the ODT. This is a business thinking in continents, not corners.
The middle of the market is the danger zone
The Frankton playbook, secure the best high-traffic site, build large-format, wait for the ecosystem to reorganise, has a cost borne elsewhere. Inside Retail reported in April 2026 that roughly 150 independent pharmacies have closed over the past five years, concentrated in the urban centres where Chemist Warehouse has expanded.
The economics are brutal for anyone caught in between. A 2021 University of Otago study, cited by Newsroom, found unfunded customer services make up between 15% and 50% of a pharmacist’s daily work, cross-subsidised by dispensing and retail revenue, a model that collapses when a volume discounter takes two-thirds of the spend. John Saywell of the Independent Pharmacy Group put the competitive reality plainly in December 2025: “We can’t compete on price, because we don’t have the economy of scale.” His forecast in The Spinoff splits the market into thirds, discounters at 30%, owner-operators offering personalised service at 30%, and a vulnerable middle 30% that hasn’t decided whether to be big and cheap or small and personal.
The regulatory wind is at its back
Government policy is moving in the chain’s favour. Newsroom reported that Associate Health Minister Casey Costello is pursuing deregulation of pharmacy ownership rules to “enable different models for pharmacy ownership,” with the Ministry of Health finding no clear evidence the existing restrictions protect patient safety. The NZ Initiative’s Dr Eric Crampton called the old rules an “odd little regulatory cartel.” Removing that cartel is the right call on principle, but it also clears the runway for the player already at scale.
What it means for landlords and tenants
The macro timing helps. Stats NZ reported on 27 June 2026 that pharmaceutical and other store-based retailing rose 2.8% in the March quarter, with South Island retail up 2.9% to $8.1 billion and Otago among the strongest regions, a favourable backdrop for a big Queenstown bet.
For B2B readers the lesson generalises well beyond pharmacy. When a scale operator anchors the best corner in a high-traffic regional centre, the surrounding commercial property market reprices around it, foot traffic concentrates, and adjacent tenants either ride the spillover or get squeezed. The consolidation isn’t slowing. For any operator in a category facing a national discounter, the most expensive place to sit is the undecided middle.
Sources
- Otago Daily Times: Cornering the pharmacy market (2026-06-28)
- BusinessDesk: Inside Chemist Warehouse’s aggressive expansion plans for NZ (2026-04-13)
- Inside Retail: Chemist Warehouse’s plan to undermine independent pharmacies revealed (2026-04-13)
- Newsroom: For pharmacists, industry changes are a hard pill to swallow (2026-02-02)
- The Spinoff: Prediction – New Zealand will eventually be one big Chemist Warehouse (2025-12-08)
- Stats NZ: Retail activity up in the March 2026 quarter (2026-06-27)